NeuraMedica Inc. — Form D/A
NeuraMedica Inc. of OREGON CITY, OR, a company, filed a Form D amendment with the SEC on 2024-11-26. The offering totals $1.0M, of which $710K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-11-26
- Form: D/A
- Accession: 0001744491-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $710K
- Remaining: $290K
- Investors: 13
- Date of first sale: 2023-06-26
- Revenue range: Decline to Disclose
- SEC file number: 021-486375
Issuer
- Name: NeuraMedica Inc.
- CIK: 0001744491
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 402 BEAVERCREEK RD, OREGON CITY, OR, 97045
- Phone: 503-802-5533
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Rachel Dreilinger | Director | OREGON CITY, OR |
| Neil Roundy | Director | OREGON CITY, OR |
| Michael Tippie | Director | OREGON CITY, OR |
| Rachel Dreilinger | Executive Officer | OREGON CITY, OR |
| Neil Roundy | Executive Officer | OREGON CITY, OR |
| Rachel Dreilinger | Promoter | OREGON CITY, OR |
| Neil Roundy | Promoter | OREGON CITY, OR |
| Michael Tippie | Executive Officer | OREGON CITY, OR |
| Michael Tippie | Promoter | OREGON CITY, OR |
| John Alleman | Director | Oregon City, OR |
| Coni Rosati | Director | OREGON CITY, OR |
| Coni Rosati | Promoter | OREGON CITY, OR |
Other filings by this issuer (4)
More